Healthpeak Properties

Current directors and officers who also hold a role at another S&P 500 company.

• Sara Grootwassink LewisFCX · DirectorWY · Director
• James B. ConnorPLD · Director

Latest Schedule 13D/13G filing per holder. Holders that reported falling below 5% are not shown. Index funds usually report once a year.

No 5% holder filings parsed yet for this company.

Open-market purchases and sales reported on Form 4. Grants, option exercises and tax withholding are excluded.

Every 8-K with Item 5.02 (departure, election or appointment of directors and officers). The text is the first paragraph of the item.

1. Apr 28, 2025

   Employee Stock Purchase Plan On January 30, 2025, the Board of Directors (the “Board”) of Healthpeak Properties, Inc. (the “Company”) adopted the Healthpeak Properties, Inc. Employee Stock Purchase Plan (the “ESPP”), subject to stockholder approval, which was obtained at the 2025 annual meeting of stockholders held on April 24, 2025 (the “Annual Meeting”), as described below. The purpose of the ESPP is to give eligible employees of the Company and those subsidiaries designated by the Compensation and Human Capital Committee of the Board (or such other committee designated by the Board) an opportunity to acquire an ownership interest in the Company by providing eligible employees the opportunity to purchase shares of the Company’s common stock at a slight discount using payroll deductions.

   Read the 8-K filing
2. Apr 24, 2025

   Appointment of Chief Financial Officer On April 24, 2025, the Board of Directors of Healthpeak Properties, Inc. (the “Company”) appointed Kelvin O. Moses as the Company’s Chief Financial Officer and principal financial officer, effective immediately, pursuant to the Company’s succession plan. Biographical information regarding Mr. Moses is included under “Our Executive Officers” in the Company’s definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on March 12, 2025 (the “2025 Proxy Statement”), which information is incorporated herein by reference. There is no arrangement or understanding between Mr. Moses and any other person pursuant to which Mr. Moses was selected as the Company’s Chief Financial Officer. Mr.

   Read the 8-K filing
3. Apr 7, 2025

   (b) Departure of Chief Financial Officer On April 2, 2025, Peter A. Scott informed Healthpeak Properties, Inc. (the “Company”) of his resignation from his position as Chief Financial Officer of the Company. Mr. Scott’s resignation from the Company is not a result of any disagreement with the Company or the Company’s external auditor. Mr. Scott is not entitled to any severance payment under the Company’s Executive Severance Plan or otherwise in connection with his voluntary resignation. The Company has a succession plan and expects to announce an internal successor in the coming weeks. A copy of the press release announcing Mr. Scott’s resignation is attached hereto as Exhibit 99.1 and incorporated herein by reference.

   Read the 8-K filing
4. Feb 3, 2025

   Executive Officer Retirement On February 3, 2025, Healthpeak Properties, Inc., a Maryland corporation (the “Company”), announced that Thomas Klaritch, currently the Company’s Chief Operating Officer, will retire from the Company. He will step down as Chief Operating Officer and leader of the outpatient medical segment effective March 1, 2025, terminate employment with the Company on September 30, 2025, and is expected to provide consulting services through the end of 2025. Mr. Klaritch will be entitled to receive the benefits due in connection with a retirement from the Company pursuant to the Company’s retirement policy, which is described in the Company’s definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on March 13, 2024 . Mr.

   Read the 8-K filing
5. Apr 26, 2024

   (b)            Departure of Directors or Certain Officers Christine N. Garvey and David B. Henry retired from the Board of Directors (the “Board”) of Healthpeak Properties, Inc. (the “Company”) effective immediately prior to the 2024 annual meeting of stockholders held on April 25, 2024 (the “Annual Meeting”). In connection with their retirements pursuant to the Company’s director term limit policy, the Board reduced its size from thirteen to eleven directors.

   Read the 8-K filing
6. Mar 1, 2024

   The information provided in the Introductory Note of this Current Report on Form 8-K is incorporated herein by reference. In connection with the Mergers and effective upon the Company Merger Effective Time, Healthpeak increased the size of the board of directors of Healthpeak (the “ Board ”) from eight members to thirteen members and appointed John T. Thomas, Tommy G. Thompson, Pamela J. Kessler, Ava E. Lias-Booker and Richard A. Weiss to the Board, with Mr. Thomas being appointed as Vice Chair of the Board, in each case, to hold office until their successors are duly elected and qualified or their earlier death, resignation or removal. There are no transactions in which Healthpeak is or was a participant and in which any of Mr. Thomas, Governor Thompson, Ms. Kessler, Ms. Lias-Booker or Mr.

   Read the 8-K filing
7. Apr 27, 2023

   2023 Performance Incentive Plan Healthpeak Properties, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”) on April 27, 2023. At the Annual Meeting, as discussed below, the Company’s stockholders approved the 2023 Performance Incentive Plan (the “2023 Plan”). The 2023 Plan was described in the section titled “ Approval of the Healthpeak Properties, Inc. 2023 Performance Incentive Plan ” in the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on March 17, 2023 (the “Proxy Statement”), which section is incorporated herein by reference. The 2023 Plan was approved, subject to stockholder approval, by the Board of Directors of the Company on February 2, 2023.

   Read the 8-K filing
8. Mar 14, 2023

   (d)    Election of Directors On March 14, 2023, the Board of Directors (the “Board”) of Healthpeak Properties, Inc., a Maryland corporation (the “Company”), appointed James B. Connor to serve as a director of the Board until the Company’s next annual meeting of stockholders and until his successor is duly elected and qualified. The Board determined that Mr. Connor qualifies as an independent director under the New York Stock Exchange listing standards and the applicable requirements of the Securities and Exchange Commission (the “SEC”). Mr. Connor has entered into the Company’s standard form of Director’s Indemnification Agreement (incorporated herein by reference to Exhibit 10.21 to the Company’s Form 10-K filed with the SEC on February 12, 2008). Mr.

   Read the 8-K filing
9. Nov 1, 2022

   On November 1, 2022, the Board of Directors of Healthpeak appointed Jeffrey H. Miller, Healthpeak’s Executive Vice President, as General Counsel, effective November 1, 2022. Mr. Miller succeeds Troy E. McHenry, who mutually agreed with Healthpeak to step down from his position as Chief Legal Officer and General Counsel, effective November 1, 2022. Mr. Miller joined Healthpeak in 2018 and has served in a variety of senior operational leadership roles. Prior to that, Mr. Miller served as Chief Operating Officer at Welltower, Inc. from 2014 to 2017, and General Counsel from 2004 to 2014. In connection with Mr. McHenry’s departure from Healthpeak, he has executed a release agreement with Healthpeak (the “Release Agreement”) and, subject to his non-revocation of the Release Agreement and compliance with certain restrictive covenants set forth in the Release Agreement, Mr.

   Read the 8-K filing
10. Oct 6, 2022

    Thomas M. Herzog Stepping Down as Chief Executive Officer and Director On October 6, 2022, Healthpeak Properties, Inc. (the “Company”) and Thomas M. Herzog mutually agreed that Mr. Herzog would step down from his position as Chief Executive Officer and from the board of directors (the “Board”) of the Company, effective immediately. Mr. Herzog’s decision to step down was not due to any disagreements on any matter relating to the Company’s operations, policies or practices. In connection with Mr. Herzog stepping down from his position, subject to his execution and non-revocation of an effective release agreement (the “Release Agreement”) and compliance with certain restrictive covenants set forth in the Release Agreement, Mr.

    Read the 8-K filing
11. Jul 6, 2022

    (b) Departure of Directors or Certain Officers Lydia H. Kennard resigned from the Board of Directors (the “Board”) of Healthpeak Properties, Inc., effective July 5, 2022. In connection with her resignation, the Board reduced its size from eight to seven directors. 2

    Read the 8-K filing
12. Nov 5, 2019

    (d) Election of Directors On November 5, 2019, the Board of Directors (the “Board”) of Healthpeak Properties, Inc., a Maryland corporation (the “Company”), appointed Sara Grootwassink Lewis to serve as a director of the Board until the Company’s next annual meeting of stockholders and until her successor is duly elected and qualified, effective November 5, 2019. The Board determined that Ms. Lewis qualifies as an independent director under the New York Stock Exchange listing standards and the applicable requirements of the Securities and Exchange Commission (the “SEC”). In connection with her appointment to the Board, Ms. Lewis will receive a prorated grant of restricted stock units with a grant date fair market value of approximately $74,520 on November 7, 2019 (the “Grant Date”).

    Read the 8-K filing
13. Oct 30, 2019

    On October 24, 2019, the Board of Directors of Healthpeak Properties, Inc., formerly HCP, Inc. (the “Company”) approved the promotion of Scott M. Brinker, the Company’s current Executive Vice President and Chief Investment Officer, to serve as President and Chief Investment Officer, effective January 1, 2020. Thomas M. Herzog will continue to serve as the Company’s President and Chief Executive Officer until January 1, 2020, after which date he will continue to serve as the Company’s Chief Executive Officer. Biographical information regarding Mr. Brinker can be found in the Company’s definitive proxy statement on Schedule 14A for the Company’s 2019 annual meeting of stockholders filed with the Securities and Exchange Commission (the “SEC”) on March 14, 2019. There are no arrangements or understandings between Mr.

    Read the 8-K filing
14. Apr 30, 2019

    (b) Departure of Directors or Certain Officers Peter L. Rhein and Joseph P. Sullivan retired from the Board of Directors (the “Board”) of HCP, Inc. (the “Company”) effective immediately prior to the 2019 annual meeting of stockholders held on April 25, 2019 (the “Annual Meeting”). In connection with their retirements pursuant to the Company’s mandatory retirement policy, the Board reduced its size from nine to seven directors.

    Read the 8-K filing
15. Aug 2, 2018

    (d) Election of Directors On July 31, 2018, the Board of Directors (the “Board”) of HCP, Inc., a Maryland corporation (the “Company”), appointed Katherine M. Sandstrom to serve as a director of the Board until the Company’s next annual meeting of stockholders and until her successor is duly elected and qualified, effective August 2, 2018. The Board determined that Ms. Sandstrom qualifies as an independent director under the New York Stock Exchange listing standards and the applicable requirements of the Securities and Exchange Commission (the “SEC”). Ms. Sandstrom was appointed to the Compensation and Human Capital Committee, and the Investment and Finance Committee. In connection with her appointment to the Board, Ms. Sandstrom will receive a grant of restricted stock units with a grant date fair market value of approximately $150,000 on August 2, 2018 (the “Grant Date”).

    Read the 8-K filing

Proxy statements (DEF 14A): 2026 · 2025 · 2024 · 2023 · 2022 · 2021

From the company's 10-K XBRL data (SEC companyfacts).

People who stopped filing as an insider of this company. “Last filing” is the last Form 3/4/5, an upper bound on when they left.